ENvue Medical, Inc. Announces 1-for-12 Reverse Stock Split
TYLER, Texas, Aug. 28, 2026 (GLOBE NEWSWIRE) -- ENvue Medical, Inc. (NASDAQ:FEED) ("ENvue" or the "Company"), a commercial-stage medical technology company, today announced that a reverse stock split of the Company’s issued and outstanding common stock, par value $0.001 per share (the "Common Stock") at a ratio of 1-for-12 is expected to become effective on September 1, 2026. The Company's Common Stock will begin trading on the Nasdaq Capital Market on a post-split basis at the market open on September 1, 2026, under the Company's existing trading symbol "FEED", but will trade under a new CUSIP number, 63008J876. After giving effect to the reverse stock split of the Company’s Common Stock
